Header Logo

Connection

MANISH DESAI to Sirolimus

Back to Details
This is a "connection" page, showing publications MANISH DESAI has written about Sirolimus.
MANISH DESAI
Connection Strength
0.051
Sirolimus
  1. Outcomes after fractional flow reserve-guided percutaneous coronary intervention versus coronary artery bypass grafting (FAME 3): 5-year follow-up of a multicentre, open-label, randomised trial. Lancet. 2025 04 26; 405(10488):1481-1490.
    View in: PubMed
    Score: 0.051
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.